TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/15/2025
Back to search
Official data from USPTO
FLANAX MENSTRUAL PAIN RELIEVER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FLANAX MENSTRUAL PAIN RELIEVER
ST13
US500000090752840Class
5
Filing
90752840
Registration
7572710
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
09/20/2025
Trademark type
Word
Nice classes
5
Filing date
06/03/2021
Registration date
11/19/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/19/2024
Last transaction
09/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/01/2018
First use in commerce
07/01/2018
Drawing code
4
Owner type
17
Owner location
Arlington, VA
Examiner
SHOOR, AMIT
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
The Trustees of the Urban Pharmaceuticals Trust
Representatives
Jeannette Maurer Carmadella Lutzker & Lutzker LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
oral analgesics; topical analgesics; analgesic balm; analgesic preparations; pain relief medication; menstrual symptom treatment preparations
Publications
History of USPTO decisions and trademark events.
32 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/15/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/15/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/19/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/19/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/17/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/17/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/23/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/23/2024
IUAF
USE AMENDMENT FILED
07/22/2024
EISU
TEAS STATEMENT OF USE RECEIVED
07/22/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/23/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/28/2023
PUBO
PUBLISHED FOR OPPOSITION
11/28/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/23/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/22/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/22/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/10/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/21/2022
GNSL
LETTER OF SUSPENSION E-MAILED
09/21/2022
CNSL
SUSPENSION LETTER WRITTEN
09/21/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/22/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/22/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/22/2022
GNRT
NON-FINAL ACTION E-MAILED
02/22/2022
CNRT
NON-FINAL ACTION WRITTEN
02/22/2022
DOCK
ASSIGNED TO EXAMINER
02/17/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/26/2021
NWAP
NEW APPLICATION ENTERED
06/07/2021
Continuous trademark protection
Get notified about every new filing that threatens FLANAX MENSTRUAL PAIN RELIEVER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.